Related websites>
-
China's first self-developed carbon-ion therapy system gets market access
China's first self-developed carbon-ion therapy system has been approved by the national drug regulator and obtained market access.
-
NMPA officially joins IMDRF NCAR Exchange Program
The International Medical Device Regulators Forum held its 16th management committee meeting on Sept 19 in Yekaterinburg, Russia.
-
5th China-ASEAN Summit for Drug Development and Cooperation held in South China
The 5th China-ASEAN Summit for Drug Development and Cooperation was held in Nanning, capital of Guangxi, from Sept 20 to 21.
- NMPA Promulgated the Technical Guidelines for Clinical Trial of Recombinant Human Coagulation Factor VIII and the Technical Guidelines for Clinical Trial of Recombinant Human Coagulation Factor IX
- NMPA Promulgated the Guidelines for Clinical Safety Literature Evaluation of Marketed Drugs (Interim)
- General Office of the State Council Issued the Key Tasks for Deepening the Reform of the Pharmaceutical and Healthcare System in 2019
